Metropolitan Life Insurance CO Organon & Co. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$16.59 - $23.77 $8,991 - $12,883	-542 Reduced 4.88%	10,573 $183,000
Q2 2023 Aug 10, 2023	SELL	$19.27 - $24.63 $5,029 - $6,428	-261 Reduced 2.29%	11,115 $231,000
Q1 2023 May 15, 2023	SELL	$21.42 - $32.08 $71,435 - $106,986	-3,335 Reduced 22.67%	11,376 $267,000
Q4 2022 Jun 14, 2023	BUY	$23.31 - $28.61 $77,738 - $95,414	3,335 Added 29.32%	14,711 $411 Million
Q4 2022 Mar 30, 2023	SELL	$23.31 - $28.61 $9,999 - $12,273	-429 Reduced 2.83%	14,711 $411,000
Q4 2022 Feb 15, 2023	SELL	$23.31 - $28.61 $9,999 - $12,273	-429 Reduced 2.83%	14,711 $411,000
Q3 2022 Jun 14, 2023	BUY	$23.4 - $34.25 $88,077 - $128,917	3,764 Added 33.09%	15,140 $354 Million
Q3 2022 Mar 30, 2023	SELL	$23.4 - $34.25 $3,159 - $4,623	-135 Reduced 0.88%	15,140 $354,000
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $3,159 - $4,623	-135 Reduced 0.88%	15,140 $354,000
Q2 2022 Jun 20, 2023	BUY	$31.66 - $38.9 $123,442 - $151,671	3,899 Added 34.27%	15,275 $515,000
Q2 2022 Mar 30, 2023	SELL	$31.66 - $38.9 $11,777 - $14,470	-372 Reduced 2.38%	15,275 $515,000
Q2 2022 Aug 11, 2022	SELL	$31.66 - $38.9 $11,777 - $14,470	-372 Reduced 2.38%	15,275 $516,000
Q1 2022 Jun 20, 2023	BUY	$30.45 - $39.36 $130,051 - $168,106	4,271 Added 37.54%	15,647 $546,000
Q1 2022 Mar 30, 2023	SELL	$30.45 - $39.36 $406,050 - $524,865	-13,335 Reduced 46.01%	15,647 $546,000
Q1 2022 May 12, 2022	SELL	$30.45 - $39.36 $406,050 - $524,865	-13,335 Reduced 46.01%	15,647 $547,000
Q4 2021 Jun 21, 2023	BUY	$28.67 - $37.13 $504,764 - $653,710	17,606 Added 154.76%	28,982 $882,000
Q4 2021 Mar 30, 2023	BUY	$28.67 - $37.13 $128,326 - $166,193	4,476 Added 18.26%	28,982 $882,000
Q4 2021 Feb 15, 2022	BUY	$28.67 - $37.13 $128,326 - $166,193	4,476 Added 18.26%	28,982 $883,000
Q3 2021 Jun 21, 2023	BUY	$28.63 - $35.64 $520,350 - $647,757	18,175 Added 159.77%	29,551 $968,000
Q3 2021 Mar 30, 2023	SELL	$28.63 - $35.64 $174,471 - $217,190	-6,094 Reduced 19.92%	24,506 $803,000
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $174,471 - $217,190	-6,094 Reduced 19.92%	24,506 $804,000
Q2 2021 Jun 21, 2023	BUY	$28.45 - $38.0 $544,504 - $727,282	19,139 Added 168.24%	30,515 $923,000
Q2 2021 Mar 30, 2023	BUY	$28.45 - $38.0 $452,042 - $603,782	15,889 Added 108.01%	30,600 $925,000
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $870,570 - $1.16 Million	30,600 New	30,600 $926,000

Others Institutions Holding OGN

# of Institutions

791

Shares Held

193M

Call Options Held

1.71M

Put Options Held

865K

Black Rock Inc. New York, NY

32.6M
Shares

$485 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

30.2M
Shares

$449 Million
0.01% of portfolio
Massachusetts Financial Services CO Boston, MA

9.76M
Shares

$145 Million
0.06% of portfolio
State Street Corp Boston, MA

8.98M
Shares

$134 Million
0.01% of portfolio
Lsv Asset Management Chicago, IL

7.49M
Shares

$112 Million
0.31% of portfolio

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account